TNFRSF11B, also termed osteoprotegerin, was demonstrated to involve in the progression of gastric cancer (Luan et al., 2020), melanomas (Oliver et al., 2013) and colon cancer (Zhang et al., 2021) but little was known about its function in cervical cancer. Here, TNFRSF11B is linked to malignant colon neoplasm.